Teligent Common Stock Net 2010-2021 | TLGT

Teligent common stock net from 2010 to 2021. Common stock net can be defined as the value of common equity ownership.
Teligent Annual Common Stock Net
(Millions of US $)
2020 $0
2019 $0
2018 $1
2017 $1
2016 $1
2015 $1
2014 $1
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Teligent Quarterly Common Stock Net
(Millions of US $)
2021-06-30 $1
2021-03-31 $1
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $1
2019-12-31 $0
2019-09-30 $1
2019-06-30 $1
2019-03-31 $1
2018-12-31 $1
2018-09-30 $1
2018-06-30 $1
2018-03-31 $1
2017-12-31 $1
2017-09-30 $1
2017-06-30 $1
2017-03-31 $1
2016-12-31 $1
2016-09-30 $1
2016-06-30 $1
2016-03-31 $1
2015-12-31 $1
2015-09-30 $1
2015-06-30 $1
2015-03-31 $1
2014-12-31 $1
2014-09-30 $1
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.026B 6.88
Dr Reddy's Laboratories (RDY) India $12.288B 22.30
BridgeBio Pharma (BBIO) United States $6.503B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.775B 14.41
Bausch Health Cos (BHC) Canada $1.656B 1.21
Amphastar Pharmaceuticals (AMPH) United States $1.212B 8.14
Taysha Gene Therapies (TSHA) United States $0.582B 0.00
Personalis (PSNL) United States $0.409B 0.00
Assembly Biosciences (ASMB) United States $0.108B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00